18-74560862-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032649.6(CNDP1):c.310G>A(p.Asp104Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,612,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032649.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNDP1 | ENST00000358821.8 | c.310G>A | p.Asp104Asn | missense_variant | 4/12 | 1 | NM_032649.6 | ENSP00000351682.3 | ||
CNDP1 | ENST00000582365.1 | c.181G>A | p.Asp61Asn | missense_variant | 3/11 | 5 | ENSP00000462096.1 | |||
CNDP1 | ENST00000585136.1 | n.469-1185G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152136Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251366Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135846
GnomAD4 exome AF: 0.000108 AC: 158AN: 1460038Hom.: 0 Cov.: 31 AF XY: 0.0000758 AC XY: 55AN XY: 725914
GnomAD4 genome AF: 0.000230 AC: 35AN: 152254Hom.: 0 Cov.: 31 AF XY: 0.000282 AC XY: 21AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.310G>A (p.D104N) alteration is located in exon 4 (coding exon 4) of the CNDP1 gene. This alteration results from a G to A substitution at nucleotide position 310, causing the aspartic acid (D) at amino acid position 104 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at